Panagora Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Panagora Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-42,390	Closed	-$2.07M	–	2451
2018 Q1	$2.07M	Sell	42,390 -17,035	-29%	-$886K	0.01%	859
2017 Q4	$2.5M	Sell	59,425 -22,102	-27%	-$852K	0.01%	786
2017 Q3	$3.49M	Buy	81,527 +58,596	+256%	+$1.87M	0.01%	666
2017 Q2	$300K	Buy	+22,931	New	+$302K	﹤0.01%	1507

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Panagora Asset Management's MYOK Position: Q2 2018 in Review

Panagora Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2018, closing a stake of 42,390 shares — an estimated $2.07M sold.

Panagora Asset Management first reported a position in MYOK in Q2 2017 and held it in 4 quarters. The position peaked at $3.49M in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q2 2018.

Panagora Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Panagora Asset Management sold 42,390 MyoKardia, Inc. Common Stock shares in Q2 2018, an estimated $2.07M.
Panagora Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2017 and held it in 4 quarters.
Panagora Asset Management's MyoKardia, Inc. Common Stock position peaked at $3.49M in Q3 2017.
121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2018.

Based on Panagora Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.